Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Active Biotech AB

Market Cap 161M 17.17M 14.83M 13.66M 12.79M 23.97M 1.63B 24.34M 62.9M 794M 64.43M 63.05M 2.75B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 161M 17.17M 14.83M 13.66M 12.79M 23.97M 1.63B 24.34M 62.9M 794M 64.43M 63.05M 2.75B EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
81.52%
Yield 2026 *
-
Yield 2027 * -
1 day-5.85%
1 week-14.96%
Current month-2.55%
1 month+4.44%
3 months+42.99%
6 months+27.50%
Current year+33.04%
1 week 6
Extreme 6
7
1 month 5.3
Extreme 5.3
8.15
Current year 3.7
Extreme 3.7
9.43
1 year 3.7
Extreme 3.7
25.35
3 years 3.7
Extreme 3.7
147.8
5 years 3.7
Extreme 3.7
156
10 years 3.7
Extreme 3.7
2,190
Manager TitleAgeSince
Chief Executive Officer 64 2017-06-30
Director of Finance/CFO 75 1999-12-31
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 70 2011-04-06
Chairman 61 2019-05-22
Director/Board Member 76 2019-05-22
Change 5-day change 1-year change 3-year change Capi.($)
-5.85%-14.96%-76.00%-93.40% 17.96M
+1.03%+7.52%+54.74%+114.98% 55.58B
+2.72%+3.06%+53.28%+47.85% 43.47B
+1.12%+1.06%-14.15%-17.13% 22.64B
+1.17%-6.74%-0.13%+394.19% 20.96B
+3.81%-4.13%+16.62%-30.70% 15.79B
+0.15%+2.24%+9.06%-39.50% 15.3B
-0.69%+1.22%+28.24%+176.72% 13.45B
+5.27%+6.41%+21.05% - 11.74B
+1.61%+1.17%+90.79%+212.97% 10.96B
Average +1.03%+1.31%+18.35%+85.11% 20.99B
Weighted average by Cap. +1.71%+2.47%+33.62%+100.75%

Financials

2026 *2027 *
Net sales - -
Net income -33.2M -3.53M -3.05M -2.81M -2.63M -4.93M -336M -5.01M -12.94M -163M -13.26M -12.98M -566M 18.2M 1.94M 1.67M 1.54M 1.44M 2.7M 184M 2.75M 7.1M 89.6M 7.27M 7.11M 310M
Net Debt - -
Logo Active Biotech AB
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
Employees
5
Date Price Change Volume
26-06-11 6.120 kr -5.85% 98,574
26-06-11 6.500 kr +1.25% 84,780
26-06-10 6.420 kr +7.00% 243,168
26-06-09 6.000 kr -5.81% 128,466
26-06-08 6.370 kr -5.00% 227,169
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACTI Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!